Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$631.2M
6M shares
52-week range
$58.83 – $115.52
96% from low
Sector
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Exchange
NASDAQ
CS
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
www.mesalabs.comNo one on the platform currently holds MLAB.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 31,600 | $2.8M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-31 | $0.1600 | 2026-09-15 |
| 2026-05-29 | $0.1600 | 2026-06-15 |
| 2026-02-27 | $0.1600 | 2026-03-16 |
| 2025-11-28 | $0.1600 | 2025-12-15 |
| 2025-08-29 | $0.1600 | 2025-09-15 |
| 2025-05-30 | $0.1600 | 2025-06-16 |
| 2025-02-28 | $0.1600 | 2025-03-17 |
| 2024-11-29 | $0.1600 | 2024-12-16 |
| 2024-08-30 | $0.1600 | 2024-09-16 |
| 2024-05-31 | $0.1600 | 2024-06-14 |
No one on the platform has traded MLAB yet.
| 2024-02-28 | $0.1600 | 2024-03-15 |
| 2023-11-29 | $0.1600 | 2023-12-15 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MLAB Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $0.50 down -42.53% YoY • Reported revenue of $60.14M up 1.00% YoY
View on StockTwits ↗$MLAB Anyone else study Keith Alan Dober's watchlist methodology? Started treating mine like actual homework instead of wishlists and the difference is night and day. Still learning but finally seeing discipline pay off.
View on StockTwits ↗$MLAB - Mesa Laboratories Inc - 10K - Updated Risk Factors MLAB flags heightened exposure to global macro and geopolitical volatility, supply chain and tariff pressures, intensifying competition and consolidation, execution risk from cost-cutting and international expansion, CEO transition uncertainty, emerging AI and cybersecurity/privacy liabilities, concentration risk in dialysis calibration products, and vulnerability to catastrophic events outstripping insurance. #MedicalDevices #SupplyChainRisk #GeopoliticalVolatility #AILiability #MarketConsolidation 🟢 Added 🟠 Removed https://d-risk.ai/MLAB/10-K/2026-06-02
View on StockTwits ↗$MLAB this is dead wow.. no movement or any meaningful activity in a while ..
View on StockTwits ↗$MLAB reported 2.76 EPS and 63.72 revenue for Q4. http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_content=MLAB&utm_
View on StockTwits ↗📊 Mesa Laboratories $MLAB Q4 Earnings ✅ Earnings Beat Adj. EPS: $3.30 (beat $0.34 est.) YoY: ↑ 46.67% (from $2.25) ❌ Revenue Miss Sales: $63.724M (missed $65.171M est.) YoY: ↑ 2.56% (from $62.135M) Mesa Laboratories delivered a massive earnings beat but missed revenue estimates this quarter.
View on StockTwits ↗Wall St is expecting 1.06 EPS for $MLAB Q1 [Reporting 07/30 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$MLAB Mesa Laboratories (NASDAQ:MLAB) Director Acquires $99,940.00 in Stock
View on StockTwits ↗Wall St is expecting 1.54 EPS for $MLAB Q4 [Reporting 06/02 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB
View on StockTwits ↗$MLAB Diagnostic instruments firm with steady demand.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $259M | +3.4% | $11.78 | $11.68–$11.92 | 9.6× | 1 |
| 2028 | $272M | +5.0% | $12.36 | $12.26–$12.50 | 9.2× | 2 |
| 2029 | $281M | +3.2% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-10 | $2.63 | $2.68 | +1.9% |
| 2026-05-27 | $2.09 | $2.76 | +32.1% |
| 2026-02-03 | $1.40 | $3.07 | +119.3% |
| 2025-11-06 | $1.56 | $1.76 | +12.8% |
| 2025-08-05 | $2.46 | $2.32 | -5.7% |
| 2025-05-28 | $2.75 | $2.23 | -18.9% |
| 2025-02-04 | $1.41 | $2.67 | +89.4% |
| 2024-11-07 | $2.48 | $2.45 | -1.2% |
| $383M |
| — |
| GRVYGravity Co., Ltd. | $71.56 | +1.62% | $497M | — |
| LPTHLightPath Technologies, Inc. | $13.12 | -4.44% | $824M | — |
Source: Financial Modeling Prep · peers by sector/industry